Chuangzhen Lin - Publications

Synergistic effects of oral exclusive enteral nutrition and biologics in induction therapy for adult Crohn's disease: A real-world observational study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 05, 2025

Significance of integrated clinical and proteomic characteristics analysis for pathogenesis and management of Crohn's disease with concomitant psoriasis.

Journal: EBioMedicine

Published: March 24, 2025

The multifaceted role of Sestrin 3 (SESN3) in oxidative stress, inflammation and tumorigenesis.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: February 19, 2025

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity.

Journal: Frontiers in pharmacology

Published: January 06, 2024

A 9-year-old patient with indolent NK cell lymphoproliferative disorder: What role does an inherited SESN3 mutation play?

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 15, 2023

Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.

Journal: Frontiers in immunology

Published: June 16, 2023

Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 18, 2022

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice.

Journal: Frontiers in pharmacology

Published: February 21, 2022

Spontaneous Perforation in Crohn's Disease: A Report of Two Cases.

Journal: Inflammatory bowel diseases

Published: November 09, 2021